Former APIC ceo joins Beckton, Dickinson

Kathy Warye becomes vice president, Infection Prevention

Becton, Dickinson and Company (BD), a global medical technology company, has appointed Kathy Warye as vice president, Infection Prevention.

Prior to joining BD, Warye was chief executive of the Association for Professionals in Infection Control and Epidemiology (APIC), a position she has held for the past six years.

Warye will be based in Washington, DC and takes responsibility for building BD’s relationships with organisations committed to preventing healthcare-associated infections and will work with key opinion leaders globally to define and promote effective methods for reducing infections in the healthcare setting.

Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 people in more than 50 countries.

BD develops, manufactures and sells medical devices, instrument systems and reagents.

You may also like

Infection Control

LexaGene expands microbial panel with problem biopharma pathogen

The molecular diagnostics company has developed a <em>Burkholderia</em> test for use on its automated multiplex PCR testing product, MiQLab System
Infection Control

New strides in H2O2 biodecontamination

Since the emergence of ‘isolator technology’ in the 1980s, hydrogen peroxide has been the favoured agent for biodecontamination because the residues are benign. However, as effective use has been challenging due to a multitude of factors, it is interesting to compare a new ultrasonic dispersal method to the classic flash evaporation one. Written by Koji Kawasak and Gordon Farquharson
Infection Control

BOHS and HSE introduce free online ventilation check tool

The tool is aimed to help limit the transmission of COVID-19 in workplaces
Infection Control

Implications of operator behaviour

Personnel working in cleanrooms, have since the beginning been, and furthermore still are, the most critical elements when it comes to protecting products and processes from contamination. The question is: Can all the newly developed technologies within cleanroom technology reduce, minimise, or even fully eliminate the need of cleanroom operators? Written by Matts Ramstorp
Distribution

Protect what matters — Your Reliable Partner for Cleanroom Supplies

We ensure to consistently provide products and services that meet customers’ needs and our ambition to implement improvements constantly
Infection Control

Inconsistent findings: Should HEPA filters be used for coronavirus?

Together with the COVID-19 pandemic, the complexity of the previously presented inconsistencies due to various reasons, leaves its place in the current rewriting of the science of microbial flow and aerosol by air. Metisafe's Serdar Tuncer explains
Design & Build

Medicinal quality risk management: A holistic view

Contamination control is a continuous process in which data trends, product information and new regulatory requirements should be evaluated on an ongoing basis. Patrick Nieuwenhuizen from PharmaLex delves into the microbiological perspective
Subscribe now